Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare Burkitt lymphoma that arises from the colon.
No clinical trials have been registered for colon Burkitt lymphoma.
5 publications have been identified in PubMed for colon Burkitt lymphoma. Research spans Case Report / Case Series (80%) and Clinical Trial Publication (20%).
Fuentes-Calvo KJ (2025). [PMID: 40757068](https://pubmed.ncbi.nlm.nih.gov/40757068/). *Journal of surgical case reports*. [Case Report / Case Series]
Kang A (2025). [PMID: 40546500](https://pubmed.ncbi.nlm.nih.gov/40546500/). *Cureus*. [Case Report / Case Series]
Ho MJ (2024). [PMID: 39193479](https://pubmed.ncbi.nlm.nih.gov/39193479/). *Oxford medical case reports*. [Case Report / Case Series]
Yang XL (2024). [PMID: 38978383](https://pubmed.ncbi.nlm.nih.gov/38978383/). *Zhonghua yi xue za zhi*. [Clinical Trial Publication]
Palmer TM (2024). [PMID: 38800252](https://pubmed.ncbi.nlm.nih.gov/38800252/). *Cureus*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Nov 3, 2026, 11:44 PM UTC
Common questions about colon Burkitt lymphoma
AI-curated news mentioning colon Burkitt lymphoma
Updated Oct 7, 2026
A case study highlights scleral perforation in a young adult diagnosed with Burkitt lymphoma, contributing to the understanding of ocular complications associated with this aggressive cancer. This research adds to the body of knowledge regarding rare disease manifestations.
A case report highlights paraneoplastic myopathy as a potential initial presentation of sporadic Burkitt lymphoma in an immunocompetent adult. This finding may enhance understanding of the disease's manifestations and improve early diagnosis.
A recent study reveals a shared clonal origin between angioimmunoblastic T-cell lymphoma and Burkitt lymphoma, suggesting they evolve from a common precursor. This discovery may enhance understanding of the genetic mechanisms underlying these lymphomas.